Related Experiment Video
Updated: Jul 10, 2026

Anti-virulent Disruption of Pathogenic Biofilms using Engineered Quorum-quenching Lactonases
Published on: January 1, 2016
Virulence Characteristics and Emerging Therapies for Biofilm-Forming Acinetobacter baumannii: A Review
Karma G Dolma1, Rachana Khati1, Alok K Paul2
1Department of Microbiology, Sikkim Manipal Institute of Medical Sciences, Sikkim Manipal University, Gangtok 737102, Sikkim, India.
Abstract:
Acinetobacter species is one of the most prevailing nosocomial pathogens with a potent ability to develop antimicrobial resistance. It commonly causes infections where there is a prolonged utilization of medical devices such as CSF shunts, catheters, endotracheal tubes, and similar. There are several strains of Acinetobacter (A) species (spp), among which the majority are pathogenic to humans, but A. baumannii are entirely resistant to several clinically available antibiotics. The crucial mechanism that renders them a multidrug-resistant strain is their potent ability to synthesize biofilms. Biofilms provide ample opportunity for the microorganisms to withstand the harsh environment and further cause chronic infections. Several studies have enumerated multiple physiological and virulence factors responsible for the production and maintenance of biofilms. To further enhance our understanding of this pathogen, in this review, we discuss its taxonomy, pathogenesis, current treatment options, global resistance rates, mechanisms of its resistance against various groups of antimicrobials, and future therapeutics.
Insights
Acinetobacter species, particularly Acinetobacter baumannii, are dangerous hospital-acquired pathogens. Their ability to form biofilms drives multidrug resistance and chronic infections, necessitating a review of current treatments and future therapeutic strategies.
Area of Science:
- Microbiology
- Infectious Diseases
- Antimicrobial Resistance
Background:
- Acinetobacter species are significant nosocomial pathogens, frequently causing infections linked to medical devices.
- Acinetobacter baumannii exhibits extensive resistance to multiple antibiotics, posing a major clinical challenge.
Purpose of the Study:
- To provide a comprehensive review of Acinetobacter species, focusing on Acinetobacter baumannii.
- To discuss taxonomy, pathogenesis, biofilm formation, and antimicrobial resistance mechanisms.
- To explore current treatment strategies, global resistance rates, and future therapeutic avenues.
Main Methods:
- Literature review of Acinetobacter species, antimicrobial resistance, and biofilm formation.
- Analysis of physiological and virulence factors contributing to biofilm production.
- Synthesis of information on global resistance patterns and therapeutic options.
Main Results:
- Acinetobacter species, especially A. baumannii, are highly resistant due to biofilm synthesis.
- Biofilms are critical for pathogen survival in harsh environments and chronic infection development.
- Multiple factors contribute to biofilm formation and maintenance in Acinetobacter.
Conclusions:
- Understanding Acinetobacter's resistance mechanisms and biofilm strategies is crucial for effective treatment.
- Novel therapeutic approaches are needed to combat multidrug-resistant Acinetobacter infections.
- Continued research into Acinetobacter pathogenesis and resistance is essential for public health.
More Related Videos
07:41Author Spotlight: A Comprehensive Protocol for Acinetobacter Biofilm Quantification, Assessment, and Visualization
Published on: August 4, 2023
05:06Author Spotlight: Advancing Antibiotic Resistance Research Using an Efflux-Deficient Bacterial Strain and a Single-Copy Gene Expression System
Published on: January 5, 2024
Related Concept Videos
Biofilms
Gene Regulation in Microbial Communities: Quorum Sensing
Determinants of Bacterial Pathogenicity and Virulence
Mechanism of Antibiotic Resistance in MRSA
Clinical Significance of Antibiotic Resistance